← Back to Search

Blood Collection Device Validation for Patients Taking Blood Thinners

Verified Trial
N/A
Recruiting
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
>=18 yrs.
We are looking for participants currently on anticoagulants such as Pradaxa®, Xarelto®, Eliquis®, Coumadin®, Normiflo ®, Fragmin®, or Lovenox®.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is to help a manufacturer qualify their line of blood collection tubes with the FDA, which will help increase the supply of blood collection tubes. Participants on anticoagulants such as Pradaxa®, Xarelto®, Eliquis®, Coumadin®, Normiflo ®, Fragmin®, or Lovenox® are compensated for their time and resources (up to $200 for a 3.5 tablespoon blood draw).

Who is the study for?
This trial is for adults over 18 who are currently taking blood thinners like Pradaxa®, Xarelto®, Eliquis®, Coumadin®, Normiflo ®, Fragmin®, or Lovenox®. Participants must be able to travel to a lab for a blood draw.Check my eligibility
What is being tested?
The study aims to validate new blood collection tubes by drawing about 3.5 tablespoons of blood from participants on anticoagulants. This could help address the shortage of these tubes in US healthcare.See study design
What are the potential side effects?
Since the intervention involves only a standard blood draw, side effects may include temporary discomfort at the puncture site, light-headedness, bruising, or bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am currently taking blood thinners like Pradaxa, Xarelto, or similar.
Select...
I am taking Warfarin or Low Molecular Weight Heparin.
Select...
I am 18 years old or older.
Select...
I am currently taking blood thinners like Pradaxa, Xarelto, or similar.
Select...
I am taking Warfarin or Low Molecular Weight Heparin.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Placebo Group
Group I: ParticipantsPlacebo Group1 Intervention
Anyone on Warfarin or Low Molecular Weight Heparin

Find a Location

Who is running the clinical trial?

Media Library

Blood Draw Clinical Trial Eligibility Overview. Trial Name: BDICON35b — N/A
Taking Blood Thinners Research Study Groups: Participants
Taking Blood Thinners Clinical Trial 2023: Blood Draw Highlights & Side Effects. Trial Name: BDICON35b — N/A
Blood Draw 2023 Treatment Timeline for Medical Study. Trial Name: BDICON35b — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
65+
18 - 65
What site did they apply to?
1. Machaon Diagnostics
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. 1. Machaon Diagnostics: < 48 hours
Recent research and studies
clinicaltrials.govStudy
Device validation study using blood from patients on Warfarin or Low Molecular Weight Heparin
2022. "Device validation study using blood from patients on Warfarin or Low Molecular Weight Heparin". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/BDICON35b.
All > Ic
~124 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top